Our lead candidate, PDC*lung, is currently in the phase 1b/2 clinical trial for Non-Small Cell Lung Cancer.
PDC*line Pharma plans to conduct clinical trials to reach clinical proof of concept by 2022/2023.
PDC*line Pharma SAS
29 avenue du Maquis du Grésivaudan
38701 La Tronche
PDC*line Pharma SA
CHU - Tour 5 (B34) – GIGA
Avenue de l'Hôpital 11